brentuximab vedotin
| Product Overview | |
| Generic Name | brentuximab vedotin |
| Brand Name(s) | Adcetris® |
| Form | Powder for concentrate for solution for infusion; single-use vial; intravenous use |
| Strength | 50 mg |
| Therapeutic Class | Antineoplastic agent; monoclonal antibody and antibody-drug conjugate (CD30-directed ADC) |
| ATC Code | L01FX05 |
| Manufacturing & Regulatory | |
| GMP Compliance | WHO-GMP, EU-GMP |
| COFEPRIS | Under Registration (2025) |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 10 Units |
| Shelf Life | 24 Months |
| Storage | 2–8 °C in fridge; do not freeze; |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
